Linee guida ESC 2021 per la prevenzione delle malattie cardiovascolari nella pratica clinica elaborate dalla Task Force per la prevenzione delle malattie cardiovascolari nella pratica clinica costituita da rappresentanti della Società Europea di Cardiologia e di 12 società medico-scientifiche con il contributo straordinario dell’Associazione Europea di Cardiologia Preventiva (EAPC)

Translated title of the contribution: ESC 2021 Guidelines on cardiovascular disease prevention in clinical practice developed by the Task Force for the Prevention of Cardiovascular Diseases in Clinical Practice consisting of representatives of the European Society of Cardiology and 12 medical-scientific societies with the extraordinary contribution of the European Association of Preventive Cardiology (EAPC)

ESC Scientific Document Group

Research output: Contribution to journalArticlepeer-review

Translated title of the contributionESC 2021 Guidelines on cardiovascular disease prevention in clinical practice developed by the Task Force for the Prevention of Cardiovascular Diseases in Clinical Practice consisting of representatives of the European Society of Cardiology and 12 medical-scientific societies with the extraordinary contribution of the European Association of Preventive Cardiology (EAPC)
Original languageItalian
Pages (from-to)e3-e115
JournalGiornale italiano di cardiologia (2006)
Volume23
Issue number6 Suppl 1
DOIs
StatePublished - Jun 1 2022
Externally publishedYes

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine

Keywords

  • Primary Prevention
  • Cardiovascular Diseases/drug therapy
  • Europe
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use

Cite this